About

Touch to Test technology sets us apart

Your results in minutes

Who We Are

We develop and manufacture “Touch to Test” over-the-counter and point of care diagnostic tests that yield results in minutes. Our patented approach allows for virtually any immunological assay to be accurately performed onsite in one step using a tiny amount of capillary blood or in some cases, saliva. We envision a world where people have greater access to in-home testing with in-home results – in minutes. We are committed to changing healthcare by providing accessible, affordable, and accurate testing for all.

Our Leadership

About

Todd Grice

VP of Sales

About

John Miller

Chief Financial Officer

Dr. Jody Berry, Ph.D. / Chief Scientific Officer

About

Dr. Jody Berry, Ph.D.

Chief Scientific Officer

Kevin Clark / NOWDx Co-founder & CEO of Animal Health

About

Kevin Clark

NOWDx Co-founder & CEO of Animal Health

About

Robert Weigle

Chief Executive Officer

Dr. Stephen S. Tang, Ph.D., MBA / Board Chairman

About

Dr. Stephen S. Tang, Ph.D., MBA

Board Chairman

10

Countries

14

Distributors

320k

Test Sold

Check out what is making the news

Find out the latest news

More News

NOWDiagnostics First To Know® Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use

August 16, 2024

First and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announce...

NOWDiagnostics Secures $22.5 Million in Series B Funding

July 9, 2024

SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced it has raised $22.5 million in Series B financing. Led by DigitalDx Ventures, with notable inves...

NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board

March 21, 2024

SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostics tests and first-in-class technology and platforms, today announced the appointment of Dr. Stephen S. Tang, Ph.D., MBA, as th...